Stine K. Larsen

Herlev, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment.

CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment.

Journal: Oncoimmunology

Published: July 01, 2016

Cellular immune responses towards regulatory cells.

Cellular immune responses towards regulatory cells.

Journal: Danish medical journal

Published: January 05, 2016

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer.

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer.

Journal: Oncoimmunology

Published: August 05, 2014

Broadening the repertoire of melanoma-associated T-cell epitopes.

Broadening the repertoire of melanoma-associated T-cell epitopes.

Journal: Cancer immunology, immunotherapy : CII

Published: July 04, 2014

NK cells in the tumor microenvironment.

NK cells in the tumor microenvironment.

Journal: Critical reviews in oncogenesis

Published: June 19, 2014

Spontaneous presence of FOXO3-specific T cells in cancer patients.

Spontaneous presence of FOXO3-specific T cells in cancer patients.

Journal: Oncoimmunology

Published: January 01, 2014

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase.

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 13, 2013

HLA-restricted CTL that are specific for the immune checkpoint ligand PD-L1 occur with high frequency in cancer patients.

HLA-restricted CTL that are specific for the immune checkpoint ligand PD-L1 occur with high frequency in cancer patients.

Journal: Cancer research

Published: January 19, 2013

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot.

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot.

Journal: Cells

Published: January 01, 2012

Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase.

Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase.

Journal: PloS one

Published: October 04, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026